Kura Oncology, Inc. (KURA)

Kura Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	748	677	1,068	847	932	2,157
Market Cap Growth	10.49%	-36.58%	26.07%	-9.08%	-56.80%	246.13%
Enterprise Value	216	239	633	425	396	1,847
Last Close Price	8.46	8.71	14.38	12.41	14.00	32.66
PS Ratio	7.11	12.57	-	-	-	-
PB Ratio	3.04	1.64	2.69	2.02	1.84	3.53
P/TBV Ratio	3.08	1.64	2.69	2.02	1.84	3.53
P/FCF Ratio	8.98	5.06	-	-	-	-
P/OCF Ratio	8.50	5.04	-	-	-	-
EV/Sales Ratio	2.08	4.43	-	-	-	-
EV/FCF Ratio	2.60	1.78	-	-	-	-
Debt / Equity Ratio	0.08	0.04	0.04	0.03	0.01	0.03
Debt / FCF Ratio	0.23	0.12	-	-	-	-
Asset Turnover	0.18	0.09	-	-	-	-
Quick Ratio	4.83	9.32	12.05	18.24	23.13	24.34
Current Ratio	5.12	9.46	12.26	18.56	23.26	24.49
Return on Equity (ROE)	-65.10%	-42.91%	-37.34%	-29.31%	-23.35%	-21.60%
Return on Assets (ROA)	-26.57%	-19.97%	-22.89%	-17.65%	-13.89%	-12.92%
Return on Invested Capital (ROIC)	-42.68%	-28.59%	-24.42%	-18.45%	-14.40%	-13.48%
Return on Capital Employed (ROCE)	-45.40%	-28.40%	-40.10%	-32.40%	-25.70%	-14.80%
Earnings Yield	-29.05%	-25.69%	-14.29%	-16.04%	-14.00%	-4.16%
FCF Yield	11.13%	19.76%	-11.70%	-13.07%	-11.34%	-3.34%
Buyback Yield / Dilution	-4.45%	-17.66%	-9.31%	-0.96%	-25.01%	-26.54%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q